絞り込み

16315

広告

696件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer.

Design, synthesis, and docking studies of quinazoline analogues bearing aryl semicarbazone scaffolds as potent EGFR inhibitors.

Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial.

Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.

Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR.

Management of afatinib-induced stomatitis.

Treatment Paradigms for Advanced Non-Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design.

Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?

Triplet therapy with afatinib, cetuximab and bevacizumab induces deep remission in lung cancer cells harboring EGFR T790M in vivo.

Response heterogeneity of EGFR and HER2 exon 20 insertions to covalent EGFR and HER2 inhibitors.

Prognostic value of early response assessment using (18F)FDG-PET in patients with advanced non-small cell lung cancer treated with tyrosine-kinase inhibitors.

Insight into discovery of next generation reversible TMLR inhibitors targeting EGFR activating and drug resistant T790M mutants.

Second-line afatinib administration in an elderly patient with squamous cell carcinoma.

Treatment choice in epidermal growth factor receptor mutation-positive non-small cell lung carcinoma: latest evidence and clinical implications.

Combinational therapy of crizotinib and afatinib for malignant pleural mesothelioma.

Role of epidermal growth factor receptor in lung cancer and targeted therapies.

Quantitative tyrosine phosphoproteomics of EGFR tyrosine kinase inhibitor-treated lung adenocarcinoma cells reveals potential novel biomarkers of therapeutic response.

EGFR inhibition in NSCLC: New findings…. and opened questions?

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります